Breast, Cervical, Prostate Cancer Screening Still Lower Than Before Pandemic
FRIDAY, March 3, 2023 -- Among age-eligible adults in the United States, the prevalence of past-year screening for breast, cervical, and prostate cancer continued to be lower in 2021 than prepandemic levels, according to a study published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 3, 2023 Category: Pharmaceuticals Source Type: news
Kenya: Boys Set for HPV Vaccine in Efforts to Tame Cervical Cancer Linked to Sex
[Capital FM] Nairobi -- The Ministry of Health is set to adopt a new approach to counter an increase in cervical cancer, which is mainly caused by the Human PapillomaVirus (HPV), through inclusion of boys in HPV vaccine roll out. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - March 1, 2023 Category: African Health Source Type: news
Will DIY smear tests save lives? As research indicates 80 per cent more women will get screening
Using a 'DIY' test for cervical cancer could spare women embarrassment - and potentially save lives. (Source: the Mail online | Health)
Source: the Mail online | Health - February 27, 2023 Category: Consumer Health News Source Type: news
Immunotherapy gives hope to women with incurable cervical cancer but it's only on NHS in Scotland
Ali Wheatland (pictured), 35, is living on borrowed time. She has cervical cancer that has spread to her kidneys. If she lived in Scotland, she'd be granted a glimmer of hope with a new immunotherapy drug. (Source: the Mail online | Health)
Source: the Mail online | Health - February 25, 2023 Category: Consumer Health News Source Type: news
Millions of Americans Missed Vital Cancer Screenings in Pandemic's 2nd Year
FRIDAY, Feb. 24, 2023 – Cancer screening rates were down again during 2021, the second year of the pandemic.
The number of women having cervical cancer screening dropped 4.4 million in 2021 compared to 2019, according to a study by the American... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 24, 2023 Category: General Medicine Source Type: news
Cancer screenings could be back to normal after millions missed during Covid-19 pandemic
Millions of people across the United States missed routine cancer screenings during the second year of the Covid-19 pandemic, with the prevalence of screening for breast, cervical and prostate cancers in the previous year falling anywhere from 6% to 15% between 2019 and 2021, according to a new study from the American Cancer Society. (Source: CNN.com - Health)
Source: CNN.com - Health - February 23, 2023 Category: Consumer Health News Source Type: news
Southern Africa: New Hope for Reducing Cervical Cancer Deaths in East and Southern Africa
[UNFPA] A poignant story about a woman from Malawi this week resonates deeply with me. At the age of 40, Mary went for cervical cancer screening and tested positive. Because the cancer had spread to her uterus, her only option was a hysterectomy. But Mary had been trying for 10 years to start a family. Sadly, she declined the operation and passed away from the disease in November last year. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 22, 2023 Category: African Health Source Type: news
What Causes Mediastinal Masses?
Discussion
The mediastinum resides in the chest and is the space bounded by the thoracic inlet cephalically, diaphragm caudally, sternum anteriorly and transverse process of the spine posteriorly, and mediastinal pleura and lungs laterally. It is divided into various compartments:
Superior mediastinum
Bounded by the thoracic inlet cephalically and a horizontal plane passing from the manubriosternal joint to the junction of T4/T5 vertebrae horizontally.
Structures include: esophagus, trachea, parts of great vessels and first branches, great veins and initial branches, thymus, vagus, phrenic and other nerves, thoracic duct...
Source: PediatricEducation.org - February 20, 2023 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
MSD pharma likely to participate when govt floats tender for vaccine against cervical cancer
The Serum Institute's made-in-India vaccine against cervical cancer, CERVAVAC, was launched last month. Prakash Kumar Singh, Director of Government and Regulatory Affairs at the Serum Institute of India (SII), wrote a letter to the Health Ministry recently, saying its first indigenous HPV vaccine will be available in the private market at an MRP of Rs 2,000 per dose, it has been learnt. CERVAVAC will be available in two-dose glass vial presentation. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 15, 2023 Category: Pharmaceuticals Source Type: news
Vaccination of girls against cervical cancer likely to begin in six states in June: Sources
The Union Health Ministry has drawn a roadmap to roll out HPV vaccine in the universal immunisation programme and is likely to float a global tender in April for 16.02 crore doses to be procured by 2026, official sources said. (Source: The Economic Times)
Source: The Economic Times - February 12, 2023 Category: Consumer Health News Source Type: news
Cervical cancer: Health trusts miss abnormal cells in smear tests
A 45-year-old woman says she was devastated after learning that three previous checks had been misread. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - February 9, 2023 Category: Consumer Health News Source Type: news
SII's cervical cancer vaccine to be available in market this month at Rs 2000 for two doses
According to an official source, Singh has written a letter to the Union Health Ministry mentioning that the price of its HPV vaccine for the private market will be Rs 2,000 per vial of two doses which is much lower than other available HPV vaccines. With hospitals, doctors and associations approaching the firm seeking its HPV vaccine, the Serum Institute is ready to roll out CERVAVAC in the private market from this month. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 9, 2023 Category: Pharmaceuticals Source Type: news
Why Some HPV Infections Carry More Cervical Cancer Risk
Where and how human papillomavirus integrates itself into the human genome steers the infection’s clinical outcomes, finds a large, multifaceted study. (Source: The Scientist)
Source: The Scientist - February 2, 2023 Category: Science Tags: News & Opinion Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports good results for 2022 despite decline in demand for COVID-19 products
Basel, 2 February 2023Group sales grow by 2%1 at constant exchange rates (CER) and 1% in Swiss francs, despite lower COVID-19-related sales in both divisionsPharmaceuticals Division salesincrease by 2%; continued strong growth of newer medicines more than compensating for the impact of biosimilars and lower sales of Actemra/RoActemra (severe COVID-19)Diagnostics Division salesgrow by 3%; ongoing strong momentum in base business (+7%) more than compensating for the continuing decline in the demand for COVID-19 tests in the second half of the yearHighlightsin the fourth quarter of 2022 (incl. January 2023):US approvals ofLun...
Source: Roche Media News - February 2, 2023 Category: Pharmaceuticals Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports good results for 2022 despite decline in demand for COVID-19 products
Group sales grow by 2%1 at constant exchange rates (CER) and 1% in Swiss francs, despite lower COVID-19-related sales in both divisionsPharmaceuticals Division salesincrease by 2%; continued strong growth of newer medicines more than compensating for the impact of biosimilars and lower sales of Actemra/RoActemra (severe COVID-19)Diagnostics Division salesgrow by 3%; ongoing strong momentum in base business (+7%) more than compensating for the continuing decline in the demand for COVID-19 tests in the second half of the yearHighlightsin the fourth quarter of 2022 (incl. January 2023):US approvals ofLunsumio (follicular lymp...
Source: Roche Investor Update - February 2, 2023 Category: Pharmaceuticals Source Type: news
